These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 38135289

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Reaching low-density lipoprotein cholesterol treatment targets in stable coronary artery disease: Determinants and prognostic impact.
    Bauters C, Tricot O, Lemesle G, Meurice T, Hennebert O, Farnier M, Lamblin N.
    Arch Cardiovasc Dis; 2018 Nov; 111(11):634-643. PubMed ID: 29198936
    [Abstract] [Full Text] [Related]

  • 23. Limitations of real-world treatment with atorvastatin monotherapy for lowering LDL-C in high-risk cardiovascular patients in the US.
    Marrett E, Zhao C, Zhang NJ, Zhang Q, Ramey DR, Tomassini JE, Tershakovec AM, Neff DR.
    Vasc Health Risk Manag; 2014 Nov; 10():237-46. PubMed ID: 24851051
    [Abstract] [Full Text] [Related]

  • 24. Factors associated with unattained LDL-cholesterol goals in Chinese patients with acute coronary syndrome one year after percutaneous coronary intervention.
    Zhang W, Ji F, Yu X, Wang X.
    Medicine (Baltimore); 2017 Jan; 96(1):e5469. PubMed ID: 28072688
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Lipid-Lowering Therapy and Low-Density Lipoprotein Cholesterol (LDL-C) Goal Achievement in High-Cardiovascular-Risk Patients in Fuzhou, China.
    Wang X, He Y, Wang T, Li C, Ma Z, Zhang H, Ma H, Zhao H.
    J Cardiovasc Pharmacol Ther; 2020 Jul; 25(4):307-315. PubMed ID: 31918567
    [Abstract] [Full Text] [Related]

  • 27. Predictors of LDL-cholesterol target value attainment differ in acute and chronic coronary heart disease patients: Results from DYSIS II Europe.
    Ferrieres J, De Ferrari GM, Hermans MP, Elisaf M, Toth PP, Horack M, Brudi P, Lautsch D, Bash LD, Baxter CA, Ashton V, Ambegaonkar B, Gitt AK.
    Eur J Prev Cardiol; 2018 Dec; 25(18):1966-1976. PubMed ID: 30335504
    [Abstract] [Full Text] [Related]

  • 28. Low high-density lipoprotein cholesterol is a residual risk factor associated with long-term clinical outcomes in diabetic patients with stable coronary artery disease who achieve optimal control of low-density lipoprotein cholesterol.
    Ogita M, Miyauchi K, Miyazaki T, Naito R, Konishi H, Tsuboi S, Dohi T, Kasai T, Yokoyama T, Okazaki S, Kurata T, Daida H.
    Heart Vessels; 2014 Jan; 29(1):35-41. PubMed ID: 23516028
    [Abstract] [Full Text] [Related]

  • 29. Systematic underutilisation of secondary preventive drugs in patients with acute coronary syndrome and reduced renal function.
    Khedri M, Szummer K, Carrero JJ, Jernberg T, Evans M, Jacobson SH, Spaak J.
    Eur J Prev Cardiol; 2017 May; 24(7):724-734. PubMed ID: 28195517
    [Abstract] [Full Text] [Related]

  • 30. Long-term statin adherence in patients after hospital discharge for new onset of atherosclerotic cardiovascular disease: a population-based study of real world prescriptions in Taiwan.
    Chen ST, Huang ST, Shau WY, Lai CL, Li JZ, Fung S, Tse VC, Lai MS.
    BMC Cardiovasc Disord; 2019 Mar 15; 19(1):62. PubMed ID: 30876393
    [Abstract] [Full Text] [Related]

  • 31. Nurse-led telephone-based follow-up of secondary prevention after acute coronary syndrome: One-year results from the randomized controlled NAILED-ACS trial.
    Huber D, Henriksson R, Jakobsson S, Mooe T.
    PLoS One; 2017 Mar 15; 12(9):e0183963. PubMed ID: 28886083
    [Abstract] [Full Text] [Related]

  • 32. Effects of a pharmaceutical care intervention on clinical outcomes and patient adherence in coronary heart disease: the MIMeRiC randomized controlled trial.
    Östbring MJ, Eriksson T, Petersson G, Hellström L.
    BMC Cardiovasc Disord; 2021 Aug 01; 21(1):367. PubMed ID: 34334142
    [Abstract] [Full Text] [Related]

  • 33. Lipid-lowering treatment and low-density lipoprotein cholesterol target achievement in patients with type 2 diabetes and acute coronary syndrome.
    Ferrières J, Lautsch D, Bramlage P, Horack M, Baxter CA, Ambegaonkar B, Toth PP, Poh KK, De Ferrari GM, Gitt AK.
    Arch Cardiovasc Dis; 2020 Oct 01; 113(10):617-629. PubMed ID: 32873522
    [Abstract] [Full Text] [Related]

  • 34. Patient characteristics, treatment patterns, and adherence to lipid-lowering therapies following an acute coronary syndrome.
    Bruckert E, Desamericq G, Khachatryan A, Ngo P, Gusto G, Sorio-Vilela F.
    Rev Cardiovasc Med; 2020 Dec 30; 21(4):643-650. PubMed ID: 33388010
    [Abstract] [Full Text] [Related]

  • 35. Lipid management in ACS: Should we go lower faster?
    Gencer B, Mach F.
    Atherosclerosis; 2018 Aug 30; 275():368-375. PubMed ID: 30015301
    [Abstract] [Full Text] [Related]

  • 36. Low-density lipoprotein cholesterol targeting with pitavastatin + ezetimibe for patients with acute coronary syndrome and dyslipidaemia: the HIJ-PROPER study, a prospective, open-label, randomized trial.
    Hagiwara N, Kawada-Watanabe E, Koyanagi R, Arashi H, Yamaguchi J, Nakao K, Tobaru T, Tanaka H, Oka T, Endoh Y, Saito K, Uchida T, Matsui K, Ogawa H.
    Eur Heart J; 2017 Aug 01; 38(29):2264-2276. PubMed ID: 28430910
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Serum Low-Density Lipoprotein Cholesterol Level After Endovascular Therapy in Patients With Claudication.
    Tomoi Y, Yamaji K, Soga Y, Hiramori S, Ando K.
    J Endovasc Ther; 2019 Jun 01; 26(3):402-410. PubMed ID: 30873910
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.